(Q34606080)

3 August 2017

Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma (English)

1 reference

3 August 2017

5

Yong Poovorawan

1 reference

PubMed ID

17708609

3 August 2017

Apiradee Theamboonlers

series ordinal

4

object named as

Apiradee Theamboonlers

1 reference

3 August 2017

3

Varocha Mahachai

1 reference

3 August 2017

2

Duangporn Thong-Ngam

1 reference

3 August 2017

1

Pisit Tangkijvanich

1 reference

PubMed ID

17708609

3 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

World Journal of Gastroenterology

3 August 2017

1 reference

3 August 2017

13

1 reference

3 August 2017

32

1 reference

3 August 2017

4345-4349

1 reference

Primary liver cancer: worldwide incidence and trends

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Diagnosis and staging of hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Expression of interleukin-18, interferon-gamma and interleukin-10 in hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

The prognostic significance of clinical and pathological features in hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Interleukin-18 regulates both Th1 and Th2 responses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Inflammation and cancer: back to Virchow?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Human IL-18 bioactivity in hematological malignancies with highly elevated serum IL-18 levels

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Interleukin-18: biological properties and clinical implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

7 July 2018

Cytokines and cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Interleukin-6: historical background, genetics and biological significance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Expression of interleukin-18 in human ovarian carcinoma and normal ovarian epithelium: evidence for defective processing in tumor cells

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250862

Chemokines and their role in tumor growth and metastasis

26 October 2018

1 reference

12 December 2020

Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage

1 reference

12 December 2020

1 reference

12 December 2020

Prognostic value of serum biological markers in patients with hepatocellular carcinoma

1 reference

12 December 2020

Modulation of interleukin-18 expression in human colon carcinoma: Consequences for tumor immune surveillance

1 reference

12 December 2020

Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma

1 reference

12 December 2020

The biology of interleukin-6

1 reference

12 December 2020

Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis

1 reference

12 December 2020

Serum interleukin 6 as a prognostic factor in patients with prostate cancer

1 reference

12 December 2020

Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma

1 reference

12 December 2020

Serum interleukin-12 levels in patients with gastric cancer

1 reference

12 December 2020

Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells

1 reference

12 December 2020

Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V13.I32.4345

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

PubMed ID

17708609